Status:

COMPLETED

Macrolane Retrospective Study

Lead Sponsor:

Galderma R&D

Conditions:

Women Who Have Had Breast Enhancement With Macrolane VRF

Eligibility:

FEMALE

Brief Summary

This is a retrospective, multicenter chart review of medical records on the use of Macrolane for female breast enhancement. The primary objective is to evaluate the safety profile of Macrolane Volume...

Eligibility Criteria

Inclusion

  • Females treated with Macrolane Volume Restoration Factor 20 and/or Volume Restoration Factor 30 for breast enhancement.
  • Signed Informed Consent

Exclusion

  • Subjects that have actively asked not to be contacted by the clinic
  • Subjects that have participated or participates in clinical studies with Macrolane for breast enhancement

Key Trial Info

Start Date :

March 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT01223963

Start Date

March 1 2010

End Date

July 1 2010

Last Update

August 26 2022

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Stureplanskliniken

Gothenburg, Sweden, 411 05

2

Akademikliniken

Malmo, Sweden, 217 53

3

Stureplanskliniken

Stockholm, Sweden, 111 44

4

Akademikliniken

Stockholm, Sweden, 115 42